PetMed Express (PETS) 10-K 27 May 14 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2014	27-May-14	Sep. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'PETMED EXPRESS INC	'	'
Entity Central Index Key	'0001040130	'	'
Trading Symbol	'pets	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Well-Known Seasoned Issuer	'No	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	20,189,440	'
Entity Public Float	'	'	$312.20
Document Type	'10-K	'	'
Document Period End Date	31-Mar-14	'	'
Amendment Flag	'false	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$18,305	$18,155
Short term investments - available for sale	15,539	15,490
Accounts receivable, less allowance for doubtful accounts of $7 and $5, respectively	1,761	1,439
Inventories - finished goods	35,727	31,601
Prepaid expenses and other current assets	1,761	1,090
Deferred tax assets	1,062	982
Prepaid income taxes	54	'
Total current assets	74,209	68,757
Nonurrent assets:	'	'
Prepaid expenses	1,996	1,430
Property and equipment, net	1,310	2,132
Intangible assets	860	860
Total assets	78,375	73,179
Current liabilities:	'	'
Accounts payable	5,768	6,454
Accrued expenses and other current liabilities	2,325	2,381
Income taxes payable	'	162
Total current liabilities	8,093	8,997
Deferred tax liabilities	65	168
Total liabilities:	8,158	9,165
Commitments and contingencies	'	'
Shareholders' equity:	'	'
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share	9	9
Common stock, $.001 par value, 40,000 shares authorized; 20,190 and 21,109 shares issued and outstanding, respectively	20	20
Additional paid-in capital	1,578	'
Retained earnings	68,647	63,987
Accumulated other comprehensive loss	-37	-2
Total shareholders' equity	70,217	64,014
Total liabilities and shareholders' equity	$78,375	$73,179

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Allowance for doubtful accounts (in dollars)	$7	$5
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	5,000	5,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	40,000	40,000
Common stock, shares issued	20,190	21,109
Common stock, shares outstanding	20,190	21,109
Convertible Preferred Stock	'	'
Preferred stock, shares issued	3	3
Preferred stock, shares outstanding	3	3
Preferred stock, liquidation preference (in dollars per share)	$4	$4

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Income Statement [Abstract]	'	'	'
Sales	$233,391	$227,829	$238,250
Cost of sales	155,774	150,708	158,085
Gross profit	77,617	77,121	80,165
Operating expenses:	'	'	'
General and administrative	21,352	21,592	22,363
Advertising	27,180	27,433	30,369
Depreciation	867	1,091	1,411
Total operating expenses	49,399	50,116	54,143
Income from operations	28,218	27,005	26,022
Other income (expense):	'	'	'
Interest income, net	185	306	288
Other, net	-4	-5	61
Total other income	181	301	349
Income before provision for income taxes	28,399	27,306	26,371
Provision for income taxes	10,427	10,141	9,712
Net income	17,972	17,165	16,659
Net change in unrealized gain (loss) on short and long term investments	-35	-46	185
Comprehensive income	$17,937	$17,119	$16,844
Net income per common share:	'	'	'
Basic (in dollars per share)	$0.90	$0.86	$0.81
Diluted (in dollars per share)	$0.90	$0.86	$0.80
Weighted average number of common shares outstanding:	'	'	'
Basic (in shares)	19,901	19,926	20,613
Diluted (in shares)	20,043	20,049	20,708
Cash dividends declared per common share	$0.66	$1.60	$0.53

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Other Comprehensive Gain (Loss)	Total
In Thousands, unless otherwise specified	Convertible
Balance at Mar. 31, 2011	$9	$22	'	$97,115	($141)	$97,005
Balance (in shares) at Mar. 31, 2011	3	22,331	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Issuance of restricted stock, net	'	'	'	'	'	'
Issuance of restricted stock, net (in shares)	'	91	'	'	'	'
Share based compensation	'	'	2,246	'	'	2,246
Dividends declared	'	'	'	-10,989	'	-10,989
Repurchased and retired shares	'	-2	-23,683	'	'	-23,685
Repurchased and retired shares (in shares)	'	-2,084	'	'	'	'
Deferred tax adjustment related to restricted stock	'	'	-240	'	'	-240
Allocation of retirement of repurchased shares of additional paid in capital and retained earnings	'	'	21,677	-21,677	'	'
Net income	'	'	'	16,659	16,659	16,659
Other comprehensive gain/loss:	'	'	'	'	'	'
Net Change in unrealized gain on short and long term investments	'	'	'	'	185	185
Total comprehensive income	'	'	'	'	16,844	16,844
Balance at Mar. 31, 2012	9	20	'	81,108	44	81,181
Balance (in shares) at Mar. 31, 2012	3	20,338	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Issuance of restricted stock, net	'	'	'	'	'	'
Issuance of restricted stock, net (in shares)	'	168	'	'	'	'
Share based compensation	'	'	1,943	'	'	1,943
Dividends declared	'	'	'	-32,080	'	-32,080
Repurchased and retired shares	'	'	-3,865	'	'	-3,865
Repurchased and retired shares (in shares)	'	-397	'	'	'	'
Deferred tax adjustment related to restricted stock	'	'	-284	'	'	-284
Allocation of retirement of repurchased shares of additional paid in capital and retained earnings	'	'	2,206	-2,206	'	'
Net income	'	'	'	17,165	17,165	17,165
Other comprehensive gain/loss:	'	'	'	'	'	'
Net Change in unrealized gain on short and long term investments	'	'	'	'	-46	-46
Total comprehensive income	'	'	'	'	17,119	17,119
Balance at Mar. 31, 2013	9	20	'	63,987	-2	64,014
Balance (in shares) at Mar. 31, 2013	3	20,109	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Issuance of restricted stock, net	'	'	'	'	'	'
Issuance of restricted stock, net (in shares)	'	81	'	'	'	'
Share based compensation	'	'	1,479	'	'	1,479
Dividends declared	'	'	'	-13,312	'	-13,312
Deferred tax adjustment related to restricted stock	'	'	99	'	'	99
Net income	'	'	'	17,972	17,972	17,972
Other comprehensive gain/loss:	'	'	'	'	'	'
Net Change in unrealized gain on short and long term investments	'	'	'	'	-35	-35
Total comprehensive income	'	'	'	'	17,937	17,937
Balance at Mar. 31, 2014	$9	$20	$1,578	$68,647	($37)	$70,217
Balance (in shares) at Mar. 31, 2014	3	20,190	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:	'	'	'
Net income	$17,972	$17,165	$16,659
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation	867	1,091	1,411
Share based compensation	1,479	1,943	2,246
Deferred income taxes	-183	-76	-56
Bad debt expense	95	56	47
(Increase) decrease in operating assets and increase (decrease) in liabilities:	'	'	'
Accounts receivable	-417	77	366
Inventories - finished goods	-4,126	-5,384	-1,077
Prepaid income taxes	-54	199	465
Prepaid expenses and other current assets	-1,237	-1,279	-205
Accounts payable	-686	-165	297
Accrued expenses and other current liabilities	-42	-499	238
Income taxes payable	-162	162	'
Net cash provided by operating activities	13,506	13,290	20,391
Cash flows from investing activities:	'	'	'
Net change in investments	-84	-5,189	12,344
Purchases of property and equipment	-45	-626	-705
Net cash provided by (used in) investing activities	-129	-5,815	11,639
Cash flows from financing activities:	'	'	'
Dividends paid	-13,326	-31,972	-10,964
Purchases of treasury stock	'	-3,865	-23,685
Tax adjustment related to stock compensation	99	-284	-240
Net cash used in financing activities	-13,227	-36,121	-34,889
Net increase (decrease) in cash and cash equivalents	150	-28,646	-2,859
Cash and cash equivalents, at beginning of year	18,155	46,801	49,660
Cash and cash equivalents, at end of year	18,305	18,155	46,801
Supplemental disclosure of cash flow information:	'	'	'
Cash paid for income taxes	10,727	10,140	9,543
Retirement of treasury stock	'	3,865	23,685
Dividends payable in accrued expenses	$262	$276	$168

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	(1)           Summary of Significant Accounting Policies
	Organization
	PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the “Company”), is a leading nationwide pet pharmacy.  The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer.  The Company markets its products through national television, online, and direct mail/print advertising campaigns, which aim to increase the recognition of the “1-800-PetMeds” brand name and “PetMeds” family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases.  The majority of all of the Company’s sales are to residents in the United States.  The Company’s executive offices are located in Pompano Beach, Florida.  The Company’s fiscal year end is March 31, and references herein to fiscal 2014, 2013, or 2012 refer to the Company’s fiscal years ended March 31, 2014, 2013, and 2012, respectively.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant intercompany transactions have been eliminated in consolidation.
	Revenue Recognition
	The Company generates revenue by selling pet medication products and pet supplies mainly to retail consumers.  The Company’s policy is to recognize revenue from product sales upon shipment, when the rights of ownership and risk of loss have passed to the customer.  Outbound shipping and handling fees are included in sales and are billed upon shipment.  Shipping expenses are included in cost of sales.  The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days.  Credit card sales minimize the accounts receivable balances relative to sales.  The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from the customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks.  The Company determines its estimates of the uncollectibility of accounts receivable by analyzing historical bad debts and current economic trends.  At March 31, 2014 and 2013, the allowance for doubtful accounts was approximately $7,000 and $5,000, respectively.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents.  Cash and cash equivalents at March 31, 2014 and 2013 consisted of the Company’s cash accounts and money market accounts with a maturity of three months or less.  The carrying amount of cash equivalents approximates fair value.  The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.  The Company has not experienced any losses in such accounts.
	Short Term Investments
	The Company’s short term investments balance consists of short term bond mutual funds.  In accordance with ASC Topic 320 (“Accounting for Certain Investments in Debt and Equity Securities”), short term investments are accounted for as available for sale securities with any changes in fair value to be reflected in other comprehensive income (loss).  The Company had a short term investments balance of $15.5 million as of both March 31, 2014 and March 31, 2013.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
	Inventories
	Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or market value using a weighted average cost method.  The Company writes down its inventory for estimated obsolescence.  The inventory reserve was approximately $90,000 and $79,000 at March 31, 2014 and 2013, respectively.
	Property and Equipment
	Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets.  The furniture, fixtures, equipment, and computer software are depreciated over periods ranging from three to seven years.  Leasehold improvements and assets under capital lease agreements are amortized over the shorter of the underlying lease agreement or the useful life of the asset.
	Long-lived Assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.
	Intangible Assets
	The intangible asset consists of a toll-free telephone number and an internet domain name.  In accordance with the ASC Topic 350 (“Goodwill and Other Intangible Assets”) the intangible assets are not being amortized, and are subject to an annual review for impairment.
	Fair Value of Financial Instruments
	The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.
	Advertising
	The Company’s advertising expenses consist primarily of television advertising, online marketing, and direct mail/print advertising.  Television advertising costs are expensed as the advertisements are televised.  Internet costs are expensed in the month incurred and direct mail/print costs are expensed when the related catalogs, brochures, and postcards are produced, distributed, or superseded.
	Business Concentrations
	The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers.  We have multiple suppliers for each of our products to obtain the lowest cost.  There were five suppliers from whom we purchased approximately 50% of all products in both fiscal 2014 and 2013.
	Accounting for Share Based Compensation
	The Company records compensation expense associated with stock options and restricted stock in accordance with ASC Topic 718 (“Share Based Payment”).  The Company adopted the modified prospective transition method provided under ASC Topic 718. The compensation expense related to all of the Company’s stock-based compensation arrangements is recorded as a component of general and administrative expenses.
	Comprehensive Income
	The Company applies ASC Topic 220 (“Reporting Comprehensive Income”) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities.  At March 31, 2014 and 2013 the Company recorded an unrealized loss of $35,000 and $46,000 on its short term investments, respectively.  At March 31, 2012 the Company recorded an unrealized gain of $75,000 on its short term investments.  At March 31, 2012 the Company also recognized an unrealized recovery of $110,000, within accumulated other comprehensive income, based upon receiving full par value of its long term investments.
	The following is a summary of our comprehensive income (in thousands):
			March 31,
			2014			2013			2012
		Net income	$	17,972		$	17,165		$	16,659
		Net change in unrealized gain (loss) on short term investments		(35	)		(46	)		75
		Redemptions on long term investments		-			-			110
		Comprehensive income	$	17,937		$	17,119		$	16,844
	Income Taxes
	The Company accounts for income taxes under the provisions of ASC Topic 740 (“Accounting for Income Taxes”) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.  The Company adopted the provisions of ASC Topic 740 (“Accounting for Uncertainty in Income Taxes”, in the first quarter of fiscal 2008.  As required by “Accounting for Uncertainty in Income Taxes” guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit.  For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.  At the adoption date, the Company applied “Accounting for Uncertainty in Income Taxes” guidance to all tax positions for which the statute of limitations remained open.  The Company files tax returns in the U.S. federal jurisdiction and Florida and Georgia.  With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March 31, 2008.  Upon implementing “Accounting for Uncertainty in Income Taxes” guidance, the Company did not recognize any additional liabilities for unrecognized tax positions.  The adoption of “Accounting for Uncertainty in Income Taxes” guidance had no material impact on the Company’s consolidated financial position, results of operations, or cash flows in fiscal 2014.  Any interest and penalties related to income taxes will be recorded to other income (expenses).
	Reclassifications
	Certain reclassifications have been made to the prior years’ consolidated financial statements to conform to the fiscal 2014 presentation.  These reclassifications had no impact on net income, shareholders’ equity or cash flows as previously reported.
	Recent Accounting Pronouncements
	The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations, or cash flows.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	(2)           Fair Value Measurements
	The Company carries various assets at fair value in the Consolidated Balance Sheets.  Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.  As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.  ASC Topic 820 (“Fair Value Measurements”) establishes a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
	Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
	Level 3 - Unobservable inputs which are supported by little or no market activity.
	The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company’s cash equivalents and short term investments are classified within Level 1.  Assets and liabilities measured at fair value are summarized below (in thousands):
					Fair Value Measurement at March 31, 2014 Using
			March 31,		Quoted Prices		Significant		Significant
			2014		in Active		Other		Unobservable
					Markets for		Observable		Inputs
					Identical Assets		Inputs		(Level 3)
					(Level 1)		(Level 2)
		Assets:
		Cash and Cash equivalents - money market funds	$	18,305	$	18,305	$	-	$	-
		Short term investments -bond mutual funds		15,539		15,539		-		-
			$	33,844	$	33,844	$	-	$	-

Property_and_Equipment

Property and Equipment	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	(3)           Property and Equipment
	Major classifications of property and equipment consist of the following (in thousands):
			March 31,
			2014			2013
		Leasehold improvements	$	1,124		$	1,116
		Computer software		2,749			2,735
		Furniture, fixtures and equipment		5,771			5,748
				9,644			9,599
		Less: accumulated depreciation		(8,334	)		(7,467	)
		Property and equipment, net	$	1,310		$	2,132

Accrued_Expenses_and_Other_Cur

Accrued Expenses and Other Current Liabilities	12 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accrued Expenses and Other Current Liabilities	'
	(4)           Accrued Expenses and Other Current Liabilities
	Major classifications of accrued expenses and other current liabilities consist of the following (in thousands):
			March 31,
			2014		2013
		Accrued sales tax	$	478	$	473
		Accrued credit card fees		275		269
		Accrued salaries and benefits		754		899
		Accrued professional expenses		275		225
		Accrued sales return allowance		143		138
		Accrued dividends payable		262		276
		Other accrued liabilities		138		101
		Accrued expenses and other current liabilities	$	2,325	$	2,381

Net_Income_Per_Share

Net Income Per Share	12 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Net Income Per Share	'
	(5)           Net Income Per Share
	In accordance with the provisions of ASC Topic 260 (“Earnings Per Share”) basic net income per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted net income per common share includes the dilutive effect of potential restricted stock and the effects of the potential conversion of preferred shares, calculated using the treasury stock method.  Unvested restricted stock, and convertible preferred shares issued by the Company represent the only dilutive effect reflected in diluted weighted average shares outstanding.
	The following is a reconciliation of the numerators and denominators of the basic and diluted net income per share computations for the periods presented (in thousands, except for per share amounts):
			Year Ended March 31,
			2014		2013		2012
		Net income (numerator):
		Net income	$	17,972	$	17,165	$	16,659
		Shares (denominator)
		Weighted average number of common shares outstanding used in basic computation		19,901		19,926		20,613
		Common shares issuable upon the vesting of restricted stock		132		113		85
		Common shares issuable upon conversion of preferred shares		10		10		10
		Shares used in diluted computation		20,043		20,049		20,708
		Net income per common share:
		Basic	$	0.9	$	0.86	$	0.81
		Diluted	$	0.9	$	0.86	$	0.8
	At March 31, 2014 and 2013, all restricted stock was included in the diluted net income per common share computation.

Income_Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	(6)           Income Taxes
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are as follows (in thousands):
		March 31,
		2014			2013
	Deferred tax assets:
	Accrued expenses		679			608
	Deferred stock compensation		248			244
	Net operating loss carryforward		53			152
	Bad debt and inventory reserves		35			31
	Total deferred tax assets		1,015			1,035
	Deferred tax liabilities:
	Property and equipment		(18	)		(221	)
	Total net deferred taxes	$	997		$	814
	At March 31, 2014, the Company had federal net operating loss carryforwards of approximately $142,000.  The federal net operating loss carryforwards expire in the year 2020.  The use of such net operating loss carryforwards is limited to approximately $266,000 annually due to a change of control on November 22, 2000.
	The components of the income tax provision consist of the following (in thousands):
		Year Ended March 31,
		2014			2013			2012
	Current taxes
	Federal	$	9,689		$	9,588		$	9,138
	State		921			913			870
	Total current taxes		10,610			10,501			10,008
	Deferred taxes
	Federal		(167	)		(329	)		(270	)
	State		(16	)		(31	)		(26	)
	Total deferred taxes		(183	)		(360	)		(296	)
	Total provision for income taxes	$	10,427		$	10,141		$	9,712
	The reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense is as follows (in thousands):
		Year Ended March 31,
		2014			2013			2012
	Income taxes at U.S. statutory rates	$	9,940		$	9,557		$	9,230
	State income taxes, net of federal tax benefit		583			562			540
	Permanent differences		(35	)		(74	)		(68	)
	Other		(61	)		96			10
	Total provision for income taxes	$	10,427		$	10,141		$	9,712

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Shareholders' Equity	'
	(7)           Shareholders’ Equity
	Preferred Stock
	In April 1998, the Company issued 250,000 shares of its $.001 par value preferred stock at a price of $4.00 per share, less issuance costs of $112,187.  Each share of the preferred stock is convertible into approximately 4.05 shares of common stock at the election of the shareholder.  The shares have a liquidation value of $4.00 per share and may pay dividends at the sole discretion of the Company.  The Company does not anticipate paying dividends to the preferred shareholders in the foreseeable future.  Each share of preferred stock is entitled to one vote on all matters submitted to a vote of shareholders of the Company.  As of March 31, 2014 and 2013, 2,500 shares of the convertible preferred stock remained unconverted and outstanding.
	Share Repurchase Plan
	On November 8, 2006, the Company’s Board of Directors approved a share repurchase plan of up to $20.0 million.  On October 31, 2008, November 1, 2010, and August 1, 2011, the Company’s Board of Directors approved a second, third, and fourth share repurchase plan, respectively, each for an additional $20.0 million.  The repurchase plan is intended to be implemented through purchases made from time to time in either the open market or through private transactions at the Company’s discretion, subject to market conditions and other factors, in accordance with Securities and Exchange Commission requirements.  There can be no assurances as to the precise number of shares that will be repurchased under the share repurchase plan, and the Company may discontinue the share repurchase plan at any time subject to compliance with applicable regulatory requirements.  Shares purchased pursuant to the share repurchase plan will either be cancelled or held in the Company’s treasury.  During fiscal 2013 the Company repurchased approximately 397,000 shares of the Company’s outstanding common stock for approximately $3.9 million, averaging approximately $9.74 per share.  During fiscal 2014 the Company had no share repurchases.  As of March 31, 2014 the Company had approximately $10.2 million remaining under the Company’s share repurchase plan.
	Dividends
	On August 3, 2009, the Company’s Board of Directors declared its first quarterly dividend of $0.10 per share on its common stock.  On August 2, 2010, the Company’s Board of Directors increased the quarterly dividend to $0.125 per share, and then on January 27, 2012, the Company’s Board of Directors increased the quarterly dividend to $0.15 per share.  On December 3, 2012, the Company’s Board of Directors declared a special dividend of $1.00 per share on its common stock.  On July 26, 2013, the Company’s Board of Directors increased the quarterly dividend to $0.17 per share.  The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.
	During fiscal 2014, our Board of Directors declared the following dividends:
	Declaration Date	Per Share		Record Date	Total Amount		Payment Date
		Dividend			(In thousands)
	3-May-13	$	0.15	15-May-13	$	3,016	24-May-13
	26-Jul-13	$	0.17	12-Aug-13	$	3,433	23-Aug-13
	28-Oct-13	$	0.17	8-Nov-13	$	3,432	22-Nov-13
	30-Jan-14	$	0.17	12-Feb-14	$	3,432	21-Feb-14

Restricted_Stock

Restricted Stock	12 Months Ended
	Mar. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
Restricted Stock	'
	(8)           Restricted Stock
	On July 28, 2006, the Company received shareholder approval for the adoption of the 2006 Employee Equity Compensation Restricted Stock Plan (the “Employee Plan”) and the 2006 Outside Director Equity Compensation Restricted Stock Plan (the “Director Plan”).  The purpose of the plans is to promote the interests of the Company by securing and retaining both employees and outside directors.  The Company had reserved 1.0 million shares of common stock for issuance under the Employee Plan, and 200,000 shares of common stock for issuance under the Director Plan.  In July 2012 the Company received shareholder approval to ratify the amendment to the Company’s Director Plan passed by the Board of Directors to increase the number of shares available for issuance under the Director Plan from 200,000 to 400,000.  Additionally, the Company received shareholder approval to ratify the amendment passed by the Board of Directors to provide for a 10% automatic increase every year in the amount of shares available for issuance under each of the plans.  The value of the restricted stock is determined based on the market value of the stock at the issuance date.  The restriction period or forfeiture period is determined by the Company’s Board and is to be no less than 1 year and no more than ten years.  The Company had 731,627 restricted common shares issued under the Employee Plan and 212,000 restricted common shares issued under the Director Plan at March 31, 2014, all shares of which were issued subject to a restriction or forfeiture period which will lapse ratably on the first, second, and third anniversaries of the date of grant, and the fair value of which is being amortized over the three-year restriction period.  For the years ended March 31, 2014 and 2013, the Company recognized compensation expense related to the Employee and Director Plans of $1.5 million and $1.9 million, respectively.
	A summary of the Company’s non-vested restricted stock as of March 31, 2014 is as follows:
		Employee			Director			Both Plans Number of Shares (In thousands)
		Plan			Plan
		Number of Shares (In thousands)			Number of Shares (In thousands)
	Non-vested restricted stock outstanding at March 31, 2013		200			60			260
	Restricted stock granted		53			30			83
	Restricted stock vested		(82	)		(30	)		(112	)
	Restricted stock forfeited or expired		(1	)		-			(1	)
	Non-vested restricted stock outstanding at March 31, 2014		170			60			230
	At March 31, 2014 and 2013, there were 229,558 and 260,389 non-vested restricted stock shares outstanding, respectively.  During the fiscal years ended March 31, 2014 and 2013, the Company issued, net of forfeitures, 81,500 and 167,750 restricted shares, respectively.  At March 31, 2014 and 2013, there were $2.5 million and $2.6 million of unrecognized compensation cost related to the non-vested restricted stock awards, respectively, which is expected to be recognized over the remaining weighted average vesting period of 2.0 years and 2.5 years for fiscal 2014 and 2013, respectively.

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Mar. 31, 2014
Valuation and Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	(9)          Valuation and Qualifying Accounts
	Activity in the Company’s valuation and qualifying accounts consists of the following (in thousands):
		Year Ended March 31,
		2014			2013			2012
	Allowance for doubtful accounts:
	Balance at beginning of period	$	5		$	5		$	6
	Provision for doubtful accounts		95			56			47
	Write-off of uncollectible accounts receivable		(93	)		(56	)		(48	)
	Balance at end of year	$	7		$	5		$	5

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	(10)        Commitments and Contingencies
	Legal Matters and Routine Proceedings
	The Company has settled complaints that had been filed with various states’ pharmacy boards in the past.  There can be no assurances made that other states will not attempt to take similar actions against the Company in the future.  The Company initiates litigation to protect its trade or service marks.  There can be no assurance that the Company will be successful in protecting its trade or service marks.  Legal costs related to the above matters are expensed as incurred.
	Employment Agreements
	On January 25, 2013, the Company amended the existing Executive Employment Agreement of Menderes Akdag, the Company’s President, Chief Executive Officer, and Director, and entered into Amendment No. 4 to the Executive Employment Agreement with Mr. Akdag.  The Agreement amended certain provisions of the Executive Employment Agreement as follows: the term of the Agreement is for three years, commencing on March 16, 2013; Mr. Akdag’s salary remained at $550,000 per year throughout the term of the Agreement, and Mr. Akdag was granted 108,000 shares of restricted stock.  The restricted stock was granted on March 16, 2013, in accordance with the Company’s 2006 Employee Equity Compensation Restricted Stock Plan and the restrictions lapse ratably over a three-year period.
	Operating Lease
	The Company leases its 65,300 square foot executive offices, warehouse facility, and customer service and pharmacy contact centers under a non-cancelable operating lease.  On January 29, 2010, the Company signed a sixth addendum to its existing lease extending the terms of the lease until May 31, 2015.  The Company is responsible for certain maintenance costs, taxes, and insurance under this lease.
	The future minimum annual lease payments are as follows:
	Years Ending March 31, (in thousands)
	2015		794
	2016		133
	Total lease payments	$	927
	Rent expense was $785,000, $767,000, and $745,000 for the years ended March 31, 2014, 2013 and 2012, respectively.

Sales_by_Category

Sales by Category	12 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Sales by Category	'
	(11)        Sales by Category
	The following table provides a breakdown of the percentage of total sales by each category during the indicated periods:
		Year Ended March 31,
		2014			2013			2012
	Non-prescription medications and supplies		55	%		59	%		59	%
	Prescription medications		44	%		40	%		40	%
	Shipping and handling charges and other		1	%		1	%		1	%
	Total		100	%		100	%		100	%

Employee_Benefit_Plan

Employee Benefit Plan	12 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Employee Benefit Plan	'
	-12	Employee Benefit Plan
	The Company maintains a 401(k) Savings Plan for eligible employees.  The plan is a defined contribution plan that is administered by the Company.  All regular, full-time employees are eligible for voluntary participation upon completing one year of service and having attained the age of 21.  The plan provides for growth in savings through contributions and income from investments.  It is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended.  Plan participants are allowed to contribute a specified percentage of their base salary.  In 2006, the Company adopted a matching plan which is funded subsequent to the calendar year.  During the fiscal years ended March 31, 2014 and 2013, the Company charged $181,000 and $173,000, respectively, of 401(k) matching contribution and administration expense to general and administrative expenses.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Mar. 31, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Data (Unaudited)	'
	-13	Quarterly Financial Data (Unaudited)
	Summarized unaudited quarterly financial data for fiscal 2014 and 2013 is as follows (in thousands, except for per share amounts):
		Quarter Ended:	30-Jun-13		30-Sep-13		31-Dec-13		31-Mar-14
		Sales	$	74,194	$	60,479	$	50,086	$	48,632
		Gross Profit	$	24,013	$	19,252	$	16,889	$	17,463
		Income from operations	$	7,497	$	6,532	$	7,047	$	7,142
		Net income	$	4,755	$	4,150	$	4,541	$	4,526
		Diluted net income per common share	$	0.24	$	0.21	$	0.23	$	0.23
		Quarter Ended:	30-Jun-12		30-Sep-12		31-Dec-12		31-Mar-13
		Sales	$	68,955	$	58,145	$	49,609	$	51,120
		Gross Profit	$	22,304	$	19,370	$	17,212	$	18,235
		Income from operations	$	6,204	$	6,326	$	7,209	$	7,266
		Net income	$	3,952	$	4,034	$	4,577	$	4,602
		Diluted net income per common share	$	0.2	$	0.2	$	0.23	$	0.23

Subsequent_Events

Subsequent Events	12 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	-14	Subsequent Events
	On April 30, 2014, the Company entered into a seventh amendment of its operating lease to extend its existing lease until December 1, 2016.  On May 5, 2014, the Company’s Board of Directors declared a quarterly dividend of $0.17 per share on its common stock.  The $3.4 million dividend was paid on May 23, 2014, to shareholders of record at the close of business on May 16, 2014.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant intercompany transactions have been eliminated in consolidation.
Revenue Recognition	'
	Revenue Recognition
	The Company generates revenue by selling pet medication products and pet supplies mainly to retail consumers.  The Company’s policy is to recognize revenue from product sales upon shipment, when the rights of ownership and risk of loss have passed to the customer.  Outbound shipping and handling fees are included in sales and are billed upon shipment.  Shipping expenses are included in cost of sales.  The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days.  Credit card sales minimize the accounts receivable balances relative to sales.  The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from the customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks.  The Company determines its estimates of the uncollectibility of accounts receivable by analyzing historical bad debts and current economic trends.  At March 31, 2014 and 2013, the allowance for doubtful accounts was approximately $7,000 and $5,000, respectively.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with maturity of three months or less when purchased to be cash equivalents.  Cash and cash equivalents at March 31, 2014 and 2013 consisted of the Company’s cash accounts and money market accounts with a maturity of three months or less.  The carrying amount of cash equivalents approximates fair value.  The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits.  The Company has not experienced any losses in such accounts.
Short Term Investments	'
	Short Term Investments
	The Company’s short term investments balance consists of short term bond mutual funds.  In accordance with ASC Topic 320 (“Accounting for Certain Investments in Debt and Equity Securities”), short term investments are accounted for as available for sale securities with any changes in fair value to be reflected in other comprehensive income (loss).  The Company had a short term investments balance of $15.5 million as of both March 31, 2014 and March 31, 2013.
Use of Estimates	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Inventories	'
	Inventories
	Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or market value using a weighted average cost method.  The Company writes down its inventory for estimated obsolescence.  The inventory reserve was approximately $90,000 and $79,000 at March 31, 2014 and 2013, respectively.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of the assets.  The furniture, fixtures, equipment, and computer software are depreciated over periods ranging from three to seven years.  Leasehold improvements and assets under capital lease agreements are amortized over the shorter of the underlying lease agreement or the useful life of the asset.
Long-lived Assets	'
	Long-lived Assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets is measured by a comparison of the carrying amount of the asset to the undiscounted cash flows expected to be generated from the asset.
Intangible Assets	'
	Intangible Assets
	The intangible asset consists of a toll-free telephone number and an internet domain name.  In accordance with the ASC Topic 350 (“Goodwill and Other Intangible Assets”) the intangible assets are not being amortized, and are subject to an annual review for impairment.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to the short-term nature of these instruments.
Advertising	'
	Advertising
	The Company’s advertising expenses consist primarily of television advertising, online marketing, and direct mail/print advertising.  Television advertising costs are expensed as the advertisements are televised.  Internet costs are expensed in the month incurred and direct mail/print costs are expensed when the related catalogs, brochures, and postcards are produced, distributed, or superseded.
Business Concentrations	'
	Business Concentrations
	The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers.  We have multiple suppliers for each of our products to obtain the lowest cost.  There were five suppliers from whom we purchased approximately 50% of all products in both fiscal 2014 and 2013.
Accounting for Share Based Compensation	'
	Accounting for Share Based Compensation
	The Company records compensation expense associated with stock options and restricted stock in accordance with ASC Topic 718 (“Share Based Payment”).  The Company adopted the modified prospective transition method provided under ASC Topic 718. The compensation expense related to all of the Company’s stock-based compensation arrangements is recorded as a component of general and administrative expenses.
Comprehensive Income	'
	Comprehensive Income
	The Company applies ASC Topic 220 (“Reporting Comprehensive Income”) which requires that all items that are recognized under accounting standards as components of comprehensive income be reported in a financial statement that is displayed with the same prominence as other financial statements. The items of other comprehensive income that are typically required to be displayed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities.  At March 31, 2014 and 2013 the Company recorded an unrealized loss of $35,000 and $46,000 on its short term investments, respectively.  At March 31, 2012 the Company recorded an unrealized gain of $75,000 on its short term investments.  At March 31, 2012 the Company also recognized an unrealized recovery of $110,000, within accumulated other comprehensive income, based upon receiving full par value of its long term investments.
	The following is a summary of our comprehensive income (in thousands):
			March 31,
			2014			2013			2012
		Net income	$	17,972		$	17,165		$	16,659
		Net change in unrealized gain (loss) on short term investments		(35	)		(46	)		75
		Redemptions on long term investments		-			-			110
		Comprehensive income	$	17,937		$	17,119		$	16,844
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the provisions of ASC Topic 740 (“Accounting for Income Taxes”) which generally requires the recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.  The Company adopted the provisions of ASC Topic 740 (“Accounting for Uncertainty in Income Taxes”, in the first quarter of fiscal 2008.  As required by “Accounting for Uncertainty in Income Taxes” guidance, which clarifies ASC Topic 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit.  For tax positions meeting the more-likely-than-not threshold, the amount recognized in the Consolidated Financial Statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.  At the adoption date, the Company applied “Accounting for Uncertainty in Income Taxes” guidance to all tax positions for which the statute of limitations remained open.  The Company files tax returns in the U.S. federal jurisdiction and Florida and Georgia.  With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years ending March 31, 2008.  Upon implementing “Accounting for Uncertainty in Income Taxes” guidance, the Company did not recognize any additional liabilities for unrecognized tax positions.  The adoption of “Accounting for Uncertainty in Income Taxes” guidance had no material impact on the Company’s consolidated financial position, results of operations, or cash flows in fiscal 2014.  Any interest and penalties related to income taxes will be recorded to other income (expenses).
Reclassifications	'
	Reclassifications
	Certain reclassifications have been made to the prior years’ consolidated financial statements to conform to the fiscal 2014 presentation.  These reclassifications had no impact on net income, shareholders’ equity or cash flows as previously reported.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	The Company does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, will have a material effect on the Company’s consolidated financial position, results of operations, or cash flows.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Schedule of comprehensive income	'
		March 31,
		2014			2013			2012
	Net income	$	17,972		$	17,165		$	16,659
	Net change in unrealized gain (loss) on short term investments		(35	)		(46	)		75
	Redemptions on long term investments		-			-			110
	Comprehensive income	$	17,937		$	17,119		$	16,844

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Schedule of assets and liabilities measured at fair value	'
				Fair Value Measurement at March 31, 2014 Using
		March 31,		Quoted Prices		Significant		Significant
		2014		in Active		Other		Unobservable
				Markets for		Observable		Inputs
				Identical Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	Assets:
	Cash and Cash equivalents - money market funds	$	18,305	$	18,305	$	-	$	-
	Short term investments -bond mutual funds		15,539		15,539		-		-
		$	33,844	$	33,844	$	-	$	-

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Schedule of property plant and equipment	'
		March 31,
		2014			2013
	Leasehold improvements	$	1,124		$	1,116
	Computer software		2,749			2,735
	Furniture, fixtures and equipment		5,771			5,748
			9,644			9,599
	Less: accumulated depreciation		(8,334	)		(7,467	)
	Property and equipment, net	$	1,310		$	2,132

Accrued_Expenses_and_Other_Cur1

Accrued Expenses and Other Current Liabilities (Tables)	12 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Schedule of accrued expenses and other current liabilities	'
		March 31,
		2014		2013
	Accrued sales tax	$	478	$	473
	Accrued credit card fees		275		269
	Accrued salaries and benefits		754		899
	Accrued professional expenses		275		225
	Accrued sales return allowance		143		138
	Accrued dividends payable		262		276
	Other accrued liabilities		138		101
	Accrued expenses and other current liabilities	$	2,325	$	2,381

Net_Income_Per_Share_Tables

Net Income Per Share (Tables)	12 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of reconciliation of the numerators and denominators of the basic and diluted net income per share computations	'
		Year Ended March 31,
		2014		2013		2012
	Net income (numerator):
	Net income	$	17,972	$	17,165	$	16,659
	Shares (denominator)
	Weighted average number of common shares outstanding used in basic computation		19,901		19,926		20,613
	Common shares issuable upon the vesting of restricted stock		132		113		85
	Common shares issuable upon conversion of preferred shares		10		10		10
	Shares used in diluted computation		20,043		20,049		20,708
	Net income per common share:
	Basic	$	0.9	$	0.86	$	0.81
	Diluted	$	0.9	$	0.86	$	0.8

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of deferred tax assets and liabilities	'
		March 31,
		2014			2013
	Deferred tax assets:
	Accrued expenses		679			608
	Deferred stock compensation		248			244
	Net operating loss carryforward		53			152
	Bad debt and inventory reserves		35			31
	Total deferred tax assets		1,015			1,035
	Deferred tax liabilities:
	Property and equipment		(18	)		(221	)
	Total net deferred taxes	$	997		$	814
Schedule of components of the income tax provision	'
		Year Ended March 31,
		2014			2013			2012
	Current taxes
	Federal	$	9,689		$	9,588		$	9,138
	State		921			913			870
	Total current taxes		10,610			10,501			10,008
	Deferred taxes
	Federal		(167	)		(329	)		(270	)
	State		(16	)		(31	)		(26	)
	Total deferred taxes		(183	)		(360	)		(296	)
	Total provision for income taxes	$	10,427		$	10,141		$	9,712
Schedule of reconciliation of income tax provision	'
		Year Ended March 31,
		2014			2013			2012
	Income taxes at U.S. statutory rates	$	9,940		$	9,557		$	9,230
	State income taxes, net of federal tax benefit		583			562			540
	Permanent differences		(35	)		(74	)		(68	)
	Other		(61	)		96			10
	Total provision for income taxes	$	10,427		$	10,141		$	9,712

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Schedule of dividend declared	'
	Declaration Date	Per Share		Record Date	Total Amount		Payment Date
		Dividend			(In thousands)
	3-May-13	$	0.15	15-May-13	$	3,016	24-May-13
	26-Jul-13	$	0.17	12-Aug-13	$	3,433	23-Aug-13
	28-Oct-13	$	0.17	8-Nov-13	$	3,432	22-Nov-13
	30-Jan-14	$	0.17	12-Feb-14	$	3,432	21-Feb-14

Restricted_Stock_Tables

Restricted Stock (Tables)	12 Months Ended
	Mar. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
Schedule of non-vested restricted stock	'
		Employee			Director			Both Plans Number of Shares (In thousands)
		Plan			Plan
		Number of Shares (In thousands)			Number of Shares (In thousands)
	Non-vested restricted stock outstanding at March 31, 2013		200			60			260
	Restricted stock granted		53			30			83
	Restricted stock vested		(82	)		(30	)		(112	)
	Restricted stock forfeited or expired		(1	)		-			(1	)
	Non-vested restricted stock outstanding at March 31, 2014		170			60			230

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Mar. 31, 2014
Valuation and Qualifying Accounts [Abstract]	'
Schedule of valuation and qualifying accounts	'
		Year Ended March 31,
		2014			2013			2012
	Allowance for doubtful accounts:
	Balance at beginning of period	$	5		$	5		$	6
	Provision for doubtful accounts		95			56			47
	Write-off of uncollectible accounts receivable		(93	)		(56	)		(48	)
	Balance at end of year	$	7		$	5		$	5

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of future minimum annual lease payments	'
	Years Ending March 31, (in thousands)
	2015		794
	2016		133
	Total lease payments	$	927

Sales_by_Category_Tables

Sales by Category (Tables)	12 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Schedule of breakdown of the percentage of total sales	'
		Year Ended March 31,
		2014			2013			2012
	Non-prescription medications and supplies		55	%		59	%		59	%
	Prescription medications		44	%		40	%		40	%
	Shipping and handling charges and other		1	%		1	%		1	%
	Total		100	%		100	%		100	%

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Mar. 31, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of quarterly financial data (unaudited)	'
	Quarter Ended:	30-Jun-13		30-Sep-13		31-Dec-13		31-Mar-14
	Sales	$	74,194	$	60,479	$	50,086	$	48,632
	Gross Profit	$	24,013	$	19,252	$	16,889	$	17,463
	Income from operations	$	7,497	$	6,532	$	7,047	$	7,142
	Net income	$	4,755	$	4,150	$	4,541	$	4,526
	Diluted net income per common share	$	0.24	$	0.21	$	0.23	$	0.23
	Quarter Ended:	30-Jun-12		30-Sep-12		31-Dec-12		31-Mar-13
	Sales	$	68,955	$	58,145	$	49,609	$	51,120
	Gross Profit	$	22,304	$	19,370	$	17,212	$	18,235
	Income from operations	$	6,204	$	6,326	$	7,209	$	7,266
	Net income	$	3,952	$	4,034	$	4,577	$	4,602
	Diluted net income per common share	$	0.2	$	0.2	$	0.23	$	0.23

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Summary of our comprehensive income (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Accounting Policies [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net income	$4,526	$4,541	$4,150	$4,755	$4,602	$4,577	$4,034	$3,952	$17,972	$17,165	$16,659
Net change in unrealized gain (loss) on short term investments	'	'	'	'	'	'	'	'	-35	-46	75
Redemptions on long term investments	'	'	'	'	'	'	'	'	'	'	110
Comprehensive income	'	'	'	'	'	'	'	'	$17,937	$17,119	$16,844

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Detail Textuals) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Significant Accounting Policies [Line Items]	'	'	'
Allowance for doubtful accounts (in dollars)	$7,000	$5,000	'
Short term investments - available for sale	15,539,000	15,490,000	'
Inventory reserve	90,000	79,000	'
Unrealized gain (loss) on short term investments	-35,000	-46,000	75,000
Unrealized recovery of accumulated other comprehensive income	'	'	$110,000
Depreciation method	'straight-line method	'	'
Furniture, fixtures and equipment	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Estimated useful lives of assets	'three to seven years	'	'
Computer software	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Estimated useful lives of assets	'three to seven years	'	'
Business Concentrations | Cost of goods	'	'	'
Significant Accounting Policies [Line Items]	'	'	'
Number of suppliers	5	5	'
Percentage products purchased from suppliers	50.00%	50.00%	'

Fair_Value_Measurements_Assets

Fair Value Measurements - Assets and liabilities measured at fair value (Details) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified
Estimate of Fair Value	'
Assets:	'
Cash and cash equivalents - money market funds	$18,305
Short term investments - bond mutual funds	15,539
Assets, fair value disclosure	33,844
Quoted Prices in Active Markets for Identical Assets (Level 1)	'
Assets:	'
Cash and cash equivalents - money market funds	18,305
Short term investments - bond mutual funds	15,539
Assets, fair value disclosure	33,844
Significant Other Observable Inputs (Level 2)	'
Assets:	'
Cash and cash equivalents - money market funds	'
Short term investments - bond mutual funds	'
Assets, fair value disclosure	'
Significant Unobservable Inputs (Level 3)	'
Assets:	'
Cash and cash equivalents - money market funds	'
Short term investments - bond mutual funds	'
Assets, fair value disclosure	'

Property_and_Equipment_Major_c

Property and Equipment - Major classifications of property and equipment (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$9,644	$9,599
Less: accumulated depreciation	-8,334	-7,467
Property and equipment, net	1,310	2,132
Leasehold improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	1,124	1,116
Computer software	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	2,749	2,735
Furniture, fixtures and equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$5,771	$5,748

Accrued_Expenses_and_Other_Cur2

Accrued Expenses and Other Current Liabilities - Major classifications of accrued expenses and other current liabilities (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Payables and Accruals [Abstract]	'	'
Accrued sales tax	$478	$473
Accrued credit card fees	275	269
Accrued salaries and benefits	754	899
Accrued professional expenses	275	225
Accrued sales return allowance	143	138
Accrued dividends payable	262	276
Other accrued liabilities	138	101
Accrued expenses and other current liabilities	$2,325	$2,381

Net_Income_Per_Share_Reconcili

Net Income Per Share - Reconciliation of the numerators and denominators of the basic and diluted net income per share computations (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Net income (numerator):	'	'	'	'	'	'	'	'	'	'	'
Net income (in dollars)	$4,526	$4,541	$4,150	$4,755	$4,602	$4,577	$4,034	$3,952	$17,972	$17,165	$16,659
Shares (denominator)	'	'	'	'	'	'	'	'	'	'	'
Weighted average number of common shares outstanding used in basic computation	'	'	'	'	'	'	'	'	19,901	19,926	20,613
Common shares issuable upon the vesting of restricted stock	'	'	'	'	'	'	'	'	132	113	85
Common shares issuable upon conversion of preferred shares	'	'	'	'	'	'	'	'	10	10	10
Shares used in diluted computation	'	'	'	'	'	'	'	'	20,043	20,049	20,708
Net income per common share:	'	'	'	'	'	'	'	'	'	'	'
Basic (in dollars per share)	'	'	'	'	'	'	'	'	$0.90	$0.86	$0.81
Diluted (in dollars per share)	$0.23	$0.23	$0.21	$0.24	$0.23	$0.23	$0.20	$0.20	$0.90	$0.86	$0.80

Income_Taxes_Tax_effects_of_te

Income Taxes - Tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets:	'	'
Accrued expenses	$679	$608
Deferred stock compensation	248	244
Net operating loss carryforward	53	152
Bad debt and inventory reserves	35	31
Total deferred tax assets	1,015	1,035
Deferred tax liabilities:	'	'
Property and equipment	-18	-221
Total net deferred taxes	$997	$814

Income_Taxes_Components_of_the

Income Taxes - Components of the income tax provision (Details 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Current taxes	'	'	'
Federal	$9,689	$9,588	$9,138
State	921	913	870
Total current taxes	10,610	10,501	10,008
Deferred taxes	'	'	'
Federal	-167	-329	-270
State	-16	-31	-26
Total deferred taxes	-183	-360	-296
Total provision for income taxes	$10,427	$10,141	$9,712

Income_Taxes_Reconciliation_of

Income Taxes - Reconciliation of income tax provision computed at the U.S. federal statutory tax rates to income tax expense (Details 2) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Income Tax Disclosure [Abstract]	'	'	'
Income taxes at U.S. statutory rates	$9,940	$9,557	$9,230
State income taxes, net of federal tax benefit	583	562	540
Permanent differences	-35	-74	-68
Other	-61	96	10
Total provision for income taxes	$10,427	$10,141	$9,712

Income_Taxes_Detail_Textuals

Income Taxes (Detail Textuals) (USD $)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Federal net operating loss carryforwards	$142,000
Limitation of use of operating loss carryforwards	$266,000
Description of operating loss carryforwards use	'The use of such net operating loss carryforwards is limited to approximately $266,000 annually due to a change of control on November 22, 2000.

Shareholders_Equity_Summary_of

Shareholders' Equity - Summary of dividends declared (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014
Declaration Date May 3, 2013	'
Stockholders Equity Note [Line Items]	'
Declaration Date	3-May-13
Per Share Dividend	$0.15
Record Date	15-May-13
Total Amount (In thousands)	$3,016
Payment Date	24-May-13
Declaration Date July 26, 2013	'
Stockholders Equity Note [Line Items]	'
Declaration Date	26-Jul-13
Per Share Dividend	$0.17
Record Date	12-Aug-13
Total Amount (In thousands)	3,433
Payment Date	23-Aug-13
Declaration Date October 28, 2013	'
Stockholders Equity Note [Line Items]	'
Declaration Date	28-Oct-13
Per Share Dividend	$0.17
Record Date	8-Nov-13
Total Amount (In thousands)	3,432
Payment Date	22-Nov-13
Declaration Date January 30, 2014	'
Stockholders Equity Note [Line Items]	'
Declaration Date	30-Jan-14
Per Share Dividend	$0.17
Record Date	12-Feb-14
Total Amount (In thousands)	$3,432
Payment Date	21-Feb-14

Shareholders_Equity_Detail_Tex

Shareholders' Equity (Detail Textuals) (USD $)	1 Months Ended
	Apr. 30, 1998	Mar. 31, 2014	Mar. 31, 2013
Equity [Abstract]	'	'	'
Number of preferred shares issued	250,000	'	'
Preferred stock, par value (in dollars per share)	$0.00	$0.00	$0.00
Preferred shares, issued value (in dollars per share)	$4	'	'
Preferred shares, issuance costs	$112,187	'	'
Number of common stock converted	4.05	'	'
Liquidation value (in dollars per share)	$4	'	'
Number of voting right	'entitled to one vote	'	'
Number of shares remained unconverted and outstanding	'	2,500	2,500

Shareholders_Equity_Detail_Tex1

Shareholders' Equity (Detail Textuals 1) (USD $)	12 Months Ended		0 Months Ended			1 Months Ended	12 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2013	Mar. 31, 2012	Aug. 01, 2011	Nov. 01, 2010	Nov. 08, 2006	Oct. 31, 2008	Mar. 31, 2014	Mar. 31, 2013
			Share Repurchase Plan	Share Repurchase Plan	Share Repurchase Plan	Share Repurchase Plan	Share Repurchase Plan	Share Repurchase Plan
Stockholders Equity Note [Line Items]	'	'	'	'	'	'	'	'
Amount approved of share repurchase plan	'	'	$20,000,000	$20,000,000	$20,000,000	$20,000,000	'	'
Number of shares repurchased	'	'	'	'	'	'	'	397
Value of shares repurchased	-3,865,000	-23,685,000	'	'	'	'	'	3,900,000
Average cost of shares repurchased	'	'	'	'	'	'	'	$9.74
Value of remaining shares	'	'	'	'	'	'	$10,200,000	'

Shareholders_Equity_Detail_Tex2

Shareholders' Equity (Detail Textuals 2) (USD $)	12 Months Ended
	Mar. 31, 2014
Declaration Date August 03, 2009	'
Stockholders Equity Note [Line Items]	'
Dividend declaration date	3-Aug-09
Dividend declared (in dollars per share)	$0.10
Declaration Date August 02, 2010	'
Stockholders Equity Note [Line Items]	'
Dividend declaration date	2-Aug-10
Dividend declared (in dollars per share)	$0.13
Declaration Date January 27, 2012	'
Stockholders Equity Note [Line Items]	'
Dividend declaration date	27-Jan-12
Dividend declared (in dollars per share)	$0.15
Declaration Date December 3, 2012	'
Stockholders Equity Note [Line Items]	'
Dividend declaration date	3-Dec-12
Dividend declared (in dollars per share)	$1
Declaration Date July 26, 2013	'
Stockholders Equity Note [Line Items]	'
Dividend declaration date	26-Jul-13
Dividend declared (in dollars per share)	$0.17

Restricted_Stock_Summary_of_no

Restricted Stock - Summary of non-vested restricted stock (Details) (Restricted Stock)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Employee Plan	'
Number of Shares	'
Non-vested restricted stock outstanding at March 31, 2013	200
Restricted stock granted	53
Restricted stock vested	-82
Restricted stock forfeited or expired	-1
Non-vested restricted stock outstanding at March 31, 2014	170
Director Plan	'
Number of Shares	'
Non-vested restricted stock outstanding at March 31, 2013	60
Restricted stock granted	30
Restricted stock vested	-30
Restricted stock forfeited or expired	'
Non-vested restricted stock outstanding at March 31, 2014	60
Both Plans	'
Number of Shares	'
Non-vested restricted stock outstanding at March 31, 2013	260
Restricted stock granted	83
Restricted stock vested	-112
Restricted stock forfeited or expired	-1
Non-vested restricted stock outstanding at March 31, 2014	230

Restricted_Stock_Detail_Textua

Restricted Stock (Detail Textuals ) (Restricted Stock)	Jul. 01, 2012	Jul. 28, 2006
2006 Employee Equity Compensation Restricted Stock Plan (the "Employee Plan")	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares of common stock reserved for issuance	'	1,000,000
2006 Outside Director Equity Compensation Restricted Stock Plan (the "Director Plan")	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of shares of common stock reserved for issuance	400,000	200,000

Restricted_Stock_Detail_Textua1

Restricted Stock (Detail Textuals 1) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percentage of automatic increase in the amount of shares available for issuance	10.00%	'	'
Restriction period or forfeiture period	'no less than 1 year and no more than ten years	'	'
Compensation expense	$1,479	$1,943	$2,246
Restricted Stock | Employee Plan	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of restricted common shares issued	731,627	'	'
Restricted Stock | Director Plan	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Number of restricted common shares issued	212,000	'	'

Restricted_Stock_Detail_Textua2

Restricted Stock (Detail Textuals 2) (Restricted Stock, Employee and director equity compensation plan, USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Restricted Stock | Employee and director equity compensation plan	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Non-vested restricted stock shares outstanding	230	260
Issuance of restricted stock, net of forfeitures (in shares)	81,500	167,750
Unrecognized compensation cost related to the non-vested restricted stock awards	$2.50	$2.60
Weighted average vesting period	'2 years	'2 years 6 months

Valuation_and_Qualifying_Accou2

Valuation and Qualifying Accounts - Activity in the Company's valuation and qualifying accounts (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Allowance for doubtful accounts:	'	'	'
Provision for doubtful accounts	$95	$56	$47
Allowance for Doubtful Accounts	'	'	'
Allowance for doubtful accounts:	'	'	'
Balance at beginning of period	5	5	6
Provision for doubtful accounts	95	56	47
Write-off of uncollectible accounts receivable	-93	-56	-48
Balance at end of year	$7	$5	$5

Commitments_and_Contingencies_1

Commitments and Contingencies - Future minimum annual lease payments (Details) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'
2015	$794
2016	133
Total lease payments	$927

Commitments_and_Contingencies_2

Commitments and Contingencies (Detail Textuals) (USD $)	12 Months Ended			0 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 16, 2013
	sqft			Employment Agreement
				Mr. Akdag
Commitments and Contingencies [Line Items]	'	'	'	'
Term of agreement	'	'	'	'3 years
Salary per year throughout the term of the Agreement	'	'	'	$550,000
Number of shares of restricted stock granted	'	'	'	108,000
Restriction period	'no less than 1 year and no more than ten years	'	'	'three-year period
Area under operating lease	65,300	'	'	'
Rent expense	$785,000	$767,000	$745,000	'

Sales_by_Category_Breakdown_of

Sales by Category - Breakdown of the percentage of total sales by each category (Details) (Total sales, Customer concentration risk)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Product Information [Line Items]	'	'	'
Percentage products purchased from suppliers	100.00%	100.00%	100.00%
Non-prescription medications and supplies	'	'	'
Product Information [Line Items]	'	'	'
Percentage products purchased from suppliers	55.00%	59.00%	59.00%
Prescription medications	'	'	'
Product Information [Line Items]	'	'	'
Percentage products purchased from suppliers	44.00%	40.00%	40.00%
Shipping and handling charges and other	'	'	'
Product Information [Line Items]	'	'	'
Percentage products purchased from suppliers	1.00%	1.00%	1.00%

Employee_Benefit_Plan_Detail_T

Employee Benefit Plan (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'	'
Maximum year of service for participating in the plan	'one year	'
Maximum age for participating in the plan	'21 years	'
Matching contribution and administration expense	$181	$173

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) - Summarized unaudited quarterly financial data (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Quarterly Financial Information Disclosure [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Sales	$48,632	$50,086	$60,479	$74,194	$51,120	$49,609	$58,145	$68,955	$233,391	$227,829	$238,250
Gross profit	17,463	16,889	19,252	24,013	18,235	17,212	19,370	22,304	77,617	77,121	80,165
Income from operations	7,142	7,047	6,532	7,497	7,266	7,209	6,326	6,204	28,218	27,005	26,022
Net income	$4,526	$4,541	$4,150	$4,755	$4,602	$4,577	$4,034	$3,952	$17,972	$17,165	$16,659
Diluted net income per common share (in dollars per share)	$0.23	$0.23	$0.21	$0.24	$0.23	$0.23	$0.20	$0.20	$0.90	$0.86	$0.80

Subsequent_Events_Detail_Textu

Subsequent Events (Detail Textuals) (Subsequent Event, USD $)	1 Months Ended	0 Months Ended
In Millions, except Per Share data, unless otherwise specified	23-May-14	5-May-14
		Dividend Declared
Subsequent Event [Line Items]	'	'
Dividend declared (in dollars per share)	'	$0.17
Dividend paid	$3.40	'
Payment date	'	23-May-14
Record date	'	16-May-14